论文部分内容阅读
北京市现有中成药厂,为了进一步促进北京中成药主产的发展,着重做了如下工作。一、选方。中成药主产以中医理论为指导,把处方分为13个科门及78个病类。在分类过程中,列成四大部分:第一部分是国内外传统名牌药,有安宫牛黄丸、再造丸、牛黄清心丸、愈风宁心片、感冒清热冲剂等176个品种;第二部分是疗效较好,临床需要的218种;第三部分是传统方剂,目前临床应用较少的保留产品142种;第四部分准备淘汰的有24个品种。二、恢复传统名牌中成药。现已恢复和准备恢
In order to further promote the development of the main products of proprietary Chinese patent medicines in Beijing, the existing Chinese medicine companies have focused on the following work. First, the election party. The main production of proprietary Chinese medicine is guided by the theory of traditional Chinese medicine, and the prescription is divided into 13 sections and 78 diseases. In the classification process, they are divided into four major parts: the first part is the traditional brand-name drugs at home and abroad, and there are 176 varieties of Angong Niuhuang Pills, Zaizao Pills, Niuhuangqingxin Pills, Yufeng Ningxin Tablets, and Ganmao Qingre Granules; the second part Is a good effect, clinical needs of 218 species; the third part is the traditional prescription, the current clinical application of 142 kinds of retained products; the fourth part is prepared to eliminate 24 varieties. Second, restore traditional brand name proprietary Chinese medicines. Now restored and ready for restoration